Robert Thomas, MD
Otolaryngology · Minot, NDNPI 1720284508
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.2% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 11.5% — the pattern of someone who eats at a lot of different presentations.
Across 38 payments — averaging $41.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$182
- ARS Pharmaceuticals Operations, Inc.$175
- Neurent Medical Limited$168
- AstraZeneca$164
- Johnson & Johnson$153
- Sanofi$150
- plus $588 from 12 others
What the payments were for
- Food & beverage$1,52096%
- Education$604%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 5 | $182 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $175 |
| Neurent Medical Limited | 3 | $168 |
| AstraZeneca | 4 | $164 |
| Johnson & Johnson | 1 | $153 |
| Sanofi | 2 | $150 |
| Aerin Medical Inc. | 3 | $133 |
| Regeneron Healthcare Solutions, Inc. | 4 | $120 |
| Acclarent, Inc | 1 | $85 |
| AbbVie | 3 | $67 |
| Alk-abello, Inc | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Greer Laboratories, Inc. | 1 | $22 |
| Amgen | 1 | $20 |
| Optinose US, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Intersect ENT, Inc. | 1 | $15 |
| Cochlear Americas | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$243
- LINX Reflux Management System$153
- NEUROMARK System$134
- NEUROMARK Radiofrequency Console$134
- NUCALA$122
- NEFFY$121
- AIRSUPRA$121
How this compares
$1,580 in reported general payments places this provider in the 55th percentile of 26 otolaryngology providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 11 | $357 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Minot
- Sina KoochakzadehMinot$3K
- Ray FontenotMinot$503
- Robert FischerMinot$227
- Susan MathisonFargo$11K
- Michael ShinnersFargo$8K
- Marie-Pierre CharronBismarck$4K
- Yusuf AgamawiFargo$3K
- Spencer UetzGrand Forks$3K
- Benjamin CampbellGrand Forks$3K
- Brent NicholsFargo$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.